Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 6,331 shares at $35.56 ($228K) on 2025-04-02, disclosed to the SEC on 2025-04-04.
Scheduled sale ($228k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.56 | 2,471 | $88K | 38.6% |
| 2 | $35.56 | 2,471 | $88K | 38.6% |
| 3 | $37.03 | 500 | $19K | 8.1% |
| 4 | $37.59 | 889 | $33K | 14.7% |
| Total | $35.96 avg | 6,331 | $228K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |